×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LIVN – livanova plc - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LIVN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/25
11:03 pm
livn
LivaNova PLC (NASDAQ: LIVN) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
LivaNova PLC (NASDAQ: LIVN) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
12/19
02:41 pm
livn
How stimulating the body's largest nerve may relieve severe depression [CNN]
Low
Report
How stimulating the body's largest nerve may relieve severe depression [CNN]
12/19
01:11 pm
livn
For those with treatment-resistant depression, vagus nerve stimulation may be an answer, studies suggest [CNN]
Low
Report
For those with treatment-resistant depression, vagus nerve stimulation may be an answer, studies suggest [CNN]
12/18
08:33 am
livn
RECOVER Clinical Study Shows Meaningful Benefits of LivaNova's VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression [Yahoo! Finance]
Medium
Report
RECOVER Clinical Study Shows Meaningful Benefits of LivaNova's VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression [Yahoo! Finance]
12/18
08:30 am
livn
RECOVER Clinical Study Shows Meaningful Benefits of LivaNova’s VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression
Low
Report
RECOVER Clinical Study Shows Meaningful Benefits of LivaNova’s VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression
12/17
11:03 pm
livn
LivaNova PLC (NASDAQ: LIVN) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Medium
Report
LivaNova PLC (NASDAQ: LIVN) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
12/5
09:25 am
livn
LivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting [Yahoo! Finance]
Low
Report
LivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting [Yahoo! Finance]
12/5
09:00 am
livn
LivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting
Low
Report
LivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting
Date
Time
Symbol
Company Name
Action
%Chg
10/30/2024
06:00 am
livn
livanova plc - ordinary shares
BEAT
Report
-3.1%
livanova plc - ordinary shares
7/31/2024
06:00 am
livn
livanova plc - ordinary shares
BEAT
Report
-3.7%
livanova plc - ordinary shares
5/1/2024
06:00 am
livn
livanova plc - ordinary shares
BEAT
Report
12.3%
livanova plc - ordinary shares
2/21/2024
06:00 am
livn
livanova plc - ordinary shares
BEAT
Report
8.0%
livanova plc - ordinary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/17
05:23 pm
livn
Form 4 LivaNova PLC For: Dec 15 Filed by: Poletti Franco
Medium
Report
Form 4 LivaNova PLC For: Dec 15 Filed by: Poletti Franco
12/17
05:23 pm
livn
Form 4 LivaNova PLC For: Dec 15 Filed by: Hutchinson Michael Damon
Medium
Report
Form 4 LivaNova PLC For: Dec 15 Filed by: Hutchinson Michael Damon
12/17
05:23 pm
livn
Form 4 LivaNova PLC For: Dec 15 Filed by: Shvartsburg Alex
Medium
Report
Form 4 LivaNova PLC For: Dec 15 Filed by: Shvartsburg Alex
12/17
05:23 pm
livn
Form 4 LivaNova PLC For: Dec 15 Filed by: Barry James Christopher
Medium
Report
Form 4 LivaNova PLC For: Dec 15 Filed by: Barry James Christopher
12/17
05:22 pm
livn
Form 4 LivaNova PLC For: Dec 15 Filed by: PODLOGAR SUSAN M
Medium
Report
Form 4 LivaNova PLC For: Dec 15 Filed by: PODLOGAR SUSAN M
12/13
04:04 pm
livn
Form 4 LivaNova PLC For: Dec 11 Filed by: Bianchi Francesco
Low
Report
Form 4 LivaNova PLC For: Dec 11 Filed by: Bianchi Francesco
12/11
04:41 pm
livn
Form 144 LivaNova PLC Filed by: Bianchi Francesco
Low
Report
Form 144 LivaNova PLC Filed by: Bianchi Francesco
12/10
05:31 pm
livn
Form 144 LivaNova PLC Filed by: Hebbelinck Trui
Low
Report
Form 144 LivaNova PLC Filed by: Hebbelinck Trui
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/24
LivaNova PLC (NASDAQ: LIVN) had its price target lowered by analysts at Stifel Nicolaus from $80.00 to $40.00. They now have a "buy" rating on the stock.
9.1%
2/26 LivaNova Enters Research Collaboration with Verily to Gain New Insights into Vagus Nerve Stimulation Impact on Difficult-to-Treat Depression 7.3%
3/3 Form 4 LivaNova PLC For: Mar 01 Filed by: McDonald Damien 7.0%
3/13 LivaNova PLC (NASDAQ: LIVN) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 6.1%
4/25 LivaNova PLC (NASDAQ: LIVN) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 6.1%
4/1 Form 4 LivaNova PLC For: Mar 30 Filed by: Skeffington Keyna Pidcock 5.7%
3/30 LivaNova to Host Conference Call for First Quarter 2020 Results 5.0%
9/5 LivaNova Receives Approval from U.S. Centers for Medicare & Medicaid Services for RECOVER Clinical Study 4.7%
11/25 LivaNova PLC (NASDAQ: LIVN) had its price target raised by analysts at Stifel Nicolaus from $80.00 to $90.00. They now have a "buy" rating on the stock. 4.6%
3/26 LivaNova Autonomic Regulation Therapy for Heart Failure Findings to be Presented at American College of Cardiology and World Congress of Cardiology Virtual Meeting 4.0%
2/26 LivaNova Enters Research Collaboration with Verily to Gain New Insights into Vagus Nerve Stimulation Impact on Difficult-to-Treat Depression 7.3%
3/3 Form 4 LivaNova PLC For: Mar 01 Filed by: McDonald Damien 7.0%
3/13 LivaNova PLC (NASDAQ: LIVN) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 6.1%
4/25 LivaNova PLC (NASDAQ: LIVN) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 6.1%
4/1 Form 4 LivaNova PLC For: Mar 30 Filed by: Skeffington Keyna Pidcock 5.7%
3/30 LivaNova to Host Conference Call for First Quarter 2020 Results 5.0%
9/5 LivaNova Receives Approval from U.S. Centers for Medicare & Medicaid Services for RECOVER Clinical Study 4.7%
11/25 LivaNova PLC (NASDAQ: LIVN) had its price target raised by analysts at Stifel Nicolaus from $80.00 to $90.00. They now have a "buy" rating on the stock. 4.6%
3/26 LivaNova Autonomic Regulation Therapy for Heart Failure Findings to be Presented at American College of Cardiology and World Congress of Cardiology Virtual Meeting 4.0%
TOP News Decliners
3/17
Form 4 LivaNova PLC For: Mar 15 Filed by: Huston Thad Allen
-15.0%
3/20 LivaNova PLC (NASDAQ: LIVN) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -8.4%
3/9 LivaNova VNS Therapy System, Symmetry, Granted CE Mark for Difficult-to-Treat Depression -6.3%
2/26 Q4/2019 12/31/2019 EPS 1.000 ZacksConsensus 0.950 ActVsEst 0.050 - Beat -5.9%
4/29 Q1/2020 3/31/2020 EPS 0.330 ZacksConsensus 0.340 ActVsEst (0.010) - Miss -5.0%
10/30 Q3/2019 9/30/2019 EPS 0.840 ZacksConsensus 0.720 ActVsEst 0.120 - Beat -4.8%
10/2 LivaNova PLC (NASDAQ: LIVN) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -3.7%
3/6 LivaNova PLC (NASDAQ: LIVN) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -3.1%
9/17 Form 4 LivaNova PLC For: Sep 15 Filed by: Hebbelinck Trui -2.9%
2/8 LivaNova PLC (NASDAQ: LIVN) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -2.7%
3/20 LivaNova PLC (NASDAQ: LIVN) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -8.4%
3/9 LivaNova VNS Therapy System, Symmetry, Granted CE Mark for Difficult-to-Treat Depression -6.3%
2/26 Q4/2019 12/31/2019 EPS 1.000 ZacksConsensus 0.950 ActVsEst 0.050 - Beat -5.9%
4/29 Q1/2020 3/31/2020 EPS 0.330 ZacksConsensus 0.340 ActVsEst (0.010) - Miss -5.0%
10/30 Q3/2019 9/30/2019 EPS 0.840 ZacksConsensus 0.720 ActVsEst 0.120 - Beat -4.8%
10/2 LivaNova PLC (NASDAQ: LIVN) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -3.7%
3/6 LivaNova PLC (NASDAQ: LIVN) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -3.1%
9/17 Form 4 LivaNova PLC For: Sep 15 Filed by: Hebbelinck Trui -2.9%
2/8 LivaNova PLC (NASDAQ: LIVN) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -2.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: